Quick Answer
PALVELLA THERAPEUTICS, INC. reported Net Income of -$41.72 million for fiscal year 2025.
PALVELLA THERAPEUTICS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$41.72M | -139.3% |
| 2024 | -$17.43M | -193.3% |
| 2023 | $18.69M | +156.2% |
| 2022 | -$33.28M | +27.2% |
| 2021 | -$45.74M | -22.9% |
| 2020 | -$37.23M | -46.2% |
| 2019 | -$25.47M | +4.8% |
| 2018 | -$26.75M | -51.6% |
| 2017 | -$17.65M | +22.6% |
| 2016 | -$22.80M | -62.2% |
| 2015 | -$14.06M | -42.7% |
| 2014 | -$9.85M | -62590.7% |
| 2014 | -$15.7K | -123.7% |
| 2013 | $66.2K | +24259.1% |
| 2013 | -$274.00 | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$11.35M | -67.5% | -19.8% |
| June 30, 2025 | -$9.47M | -127.0% | -15.7% |
| March 31, 2025 | -$8.19M | -222.8% | -20.8% |
| September 30, 2024 | -$6.78M | +37.0% | -62.4% |
| June 30, 2024 | -$4.17M | -204.9% | -64.5% |
| March 31, 2024 | -$2.54M | +80.8% | +76.4% |
| September 30, 2023 | -$10.75M | -10.4% | -370.4% |
| June 30, 2023 | $3.98M | +138.5% | +130.2% |
- PALVELLA THERAPEUTICS, INC. showed a decrease of -139.3% in Net Income compared to the prior fiscal year.
- Over the 2013–2025 period, PALVELLA THERAPEUTICS, INC.’s net income has declined by 15224352.6% (from -$274.00 to -$41.72 million).
- The most recent figure is from PALVELLA THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: